Recombinant Human T-cell surface antigen CD2 (CD2)

What is the primary function of CD2 in T cell activation?

CD2 serves as a costimulatory receptor that enhances T cell activation through multiple mechanisms. It facilitates cell-cell adhesion and plays crucial roles in immunological synapse (IS) formation, IS architecture, IS composition, and recruitment of intracellular kinases to the IS . CD2 functions as a positive regulator of TCR signaling intensity, enabling T cells to respond to lower concentrations of peptide-MHC complexes. Research has demonstrated that CD2-deficient T cells require 3-10 fold more peptide to produce the same response in vitro, indicating CD2's role in lowering the activation threshold .

Methodology note: To investigate CD2's function, researchers often use CD2-deficient mouse models crossed with transgenic mice expressing specific TCRs, allowing quantitative assessment of T cell responses with and without CD2 under controlled antigenic stimulation .

How does CD2 expression vary across T cell subsets?

CD2 expression is upregulated on memory T cells and activated T cells compared to naïve T cells . This differential expression pattern suggests CD2 plays a particularly important role in memory T cell responses. Researchers investigating TILs (tumor-infiltrating lymphocytes) in colorectal cancer have observed reduced CD2 surface levels in exhausted CD127lowPD-1hi CD3+CD8+ TILs, suggesting a potential connection between CD2 expression levels and T cell exhaustion states .

Methodology note: Flow cytometry with quantitative beads can be used to determine the absolute number of CD2 molecules per cell (typically around 4.8×104 to 9.0×104 CD2 molecules/cell depending on activation state) .

What is the primary binding partner for human CD2?

The primary binding partner for human CD2 is Lymphocyte Function-associated Antigen 3 (LFA3, also known as CD58), which is expressed on antigen-presenting cells . This interaction occurs in a head-to-head orientation, spanning approximately 14 nm - the same distance as the TCR/peptide-MHC complex. This spatial arrangement is thought to position the membranes of the T cell and APC at an optimal separation distance for TCR engagement with peptide-MHC complexes .

Methodology note: Complementary mutagenesis and crystallography studies have confirmed this head-to-head binding orientation, with the crystal structure of the CD2-CD58 complex providing definitive evidence of this interaction mode .

How can I effectively study CD2 function in primary human T cells?

When investigating CD2 function in primary human T cells, several approaches yield robust results:

• CRISPR/Cas9 gene editing: To study CD2 function, CRISPR/Cas9-mediated deletion of CD2 in primary human T cells allows for direct comparison with wild-type cells. This approach has been used to generate CD2-deleted CAR-T cells to prevent fratricide when targeting CD2+ malignancies .

• CD2 blocking antibodies: Anti-CD2 monoclonal antibodies can temporarily block CD2 function, enabling time-course studies of CD2 contribution to T cell responses. Historical studies show that a single dose of anti-CD2 monoclonal antibody resulted in sustained T cell hyporesponsiveness for up to 4 weeks .

• Single-cell secretome analysis: This technique provides detailed insights into how CD2 deletion affects cytokine production at the individual cell level. Research using this approach revealed that CD2 deletion in UCART19 cells reduced frequencies of effector cytokines (Granzyme-B and IFN-γ) .

Methodology note: When interpreting results, consider that CD2 deletion effects may be more pronounced when using weak TCR agonists or lower peptide concentrations, as CD2's contribution is more significant when TCR signal strength is limited .

What experimental systems best model CD2 interactions in the immunological synapse?

Several experimental systems effectively model CD2 interactions in the immunological synapse:

• Supported lipid bilayers (SLBs): SLBs containing fluorescently labeled CD58 (LFA3) and pMHC allow visualization of CD2-CD58 localization during immunological synapse formation. This approach revealed the CD2 expression-level-dependent switch in CD2-CD58 localization between central and peripheral domains in the immunological synapse .

• Live-cell imaging techniques: Time-lapse confocal microscopy of T cell-APC conjugates enables tracking of CD2 redistribution during synapse formation. At high expression levels and with intact cytoplasmic domains, CD2 forms a peripheral "corolla" that recruits other receptors like CD28 .

• Artificial APCs with modified CD58: By engineering artificial APCs with elongated forms of CD58, researchers demonstrated that the dimensions of CD2-ligand interactions critically influence T cell antigen recognition—elongated complexes (>21 nm) inhibit rather than enhance T cell activation .

Methodology note: Combining these approaches with phospho-flow cytometry or immunofluorescence for activated signaling molecules (pSrc, LAT, PLC-γ) provides quantitative readouts of how CD2-CD58 interactions affect downstream signaling pathways .

How does CD2 deletion affect CAR-T cell function and what strategies can overcome potential limitations?

CD2 deletion in CAR-T cells has specific functional consequences:

• Reduced cytokine production: Single-cell secretome analysis shows that CD2 deletion in UCART19 (CD19-targeting CAR-T cells) reduces the frequencies of effector cytokines Granzyme-B and IFN-γ .

• Diminished anti-tumor efficacy: UCART19ΔCD2 exhibited reduced anti-tumor efficacy compared to UCART19 in CD19+ NALM6 xenograft models .

• Potential compensatory strategies: The reduced efficacy resulting from CD2 deletion can be reversed when combined with rhIL-7-hyFc, a long-acting recombinant human interleukin-7. Treatment with rhIL-7-hyFc prolongs UCART2 persistence and increases survival in tumor re-challenge models and primary patient T-ALL models in vivo .

Methodology note: When designing CD2-deleted CAR-T cells, consider incorporating cytokine support strategies or additional costimulatory domains to compensate for the loss of CD2-mediated signaling .

What is the relationship between CD2 expression levels and immunological synapse organization?

CD2 expression levels critically determine immunological synapse organization with several key findings:

• Expression-dependent localization: A CD2 expression-level-dependent switch exists in CD2-CD58 localization between central and peripheral domains in the immunological synapse. The peripheral "CD2 corolla" forms only when CD2 surface expression is sufficiently high and its cytoplasmic domain is intact .

• Corolla formation and signaling: Corolla formation and phosphorylated Src-family kinases (pSrc) in the immunological synapse increase linearly with CD2 expression. This structure recruits other ligated receptors like CD28 and boosts recruitment of activated signaling molecules including pSrc, LAT, and PLC-γ .

• PD-1 interference: High levels of PD-1 (characteristic of exhausted T cells) invade the CD2 corolla and reduce pSrc signals, potentially explaining the functional impairment observed in exhausted T cells with altered CD2 expression .

Methodology note: Quantitative imaging approaches combining super-resolution microscopy with precise quantification of receptor densities are essential for understanding these spatial relationships .

How do species differences in CD2 biology affect translation of research findings?

Important species differences in CD2 biology impact translational research:

• Ligand differences: While human CD2 binds primarily to LFA3 (CD58), mice lack LFA3 expression. Instead, murine CD2 binds CD48, which has relatively lower affinity for CD2 and can also bind CD244 .

• Expression pattern differences: CD2 is expressed on only a minor percentage of B cells in humans, while it is broadly expressed on murine B cells .

• Translational implications: These differences make direct extrapolation of murine CD2 research to human contexts uncertain. The development of suitable animal models for CD2-targeting therapies has been resource-intensive, requiring transgenic rodents or primates as relevant pre-clinical models .

Methodology note: When designing CD2-focused studies, consider using humanized mouse models expressing human CD2 and CD58, or conduct in vitro studies with human cells supplemented with carefully designed animal experiments that account for these species differences .

How is CD2 implicated in T-cell malignancies and what therapeutic approaches target this pathway?

CD2's role in T-cell malignancies and targeted therapeutic approaches include:

• Allogeneic CAR-T therapy: An allogeneic "universal" CD2-targeting CAR-T cell (UCART2) has been developed for T-cell malignancies. In this approach, the CD2 antigen is deleted from the CAR-T cells to prevent fratricide (self-killing), and the T-cell receptor is removed to prevent GvHD .

• Efficacy data: UCART2 has demonstrated efficacy against T-ALL and CTCL and prolonged the survival of tumor-engrafted NSG mice in vivo. The combination with rhIL-7-hyFc further enhanced persistence and efficacy in tumor re-challenge and primary patient T-ALL models .

• Immunomodulatory antibodies: Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro, and clinical studies have proven the safety and efficacy of CD2-targeting biologics for conditions characterized by undesired T cell activation .

Methodology note: When developing CD2-targeted therapies, consider monitoring not only direct anti-tumor effects but also potential impacts on normal immune function, given CD2's important role in memory T cell responses .

What methodological approaches can assess changes in CD2 function in exhausted T cells?

Several methodological approaches can effectively assess CD2 functional changes in exhausted T cells:

• Quantitative flow cytometry: Measurement of absolute CD2 molecule numbers per cell can identify reduced CD2 levels in exhausted T cells. Studies have found significantly lower CD2 levels (4.8×10⁴±7.6×10³ molecules/cell) in exhausted CD127⁻PD-1⁺ CD8⁺ TILs compared to healthy memory CD8⁺ T cells (7.6×10⁴±8.9×10³ molecules/cell) .

• Single-cell RNA sequencing: This approach can correlate CD2 expression with exhaustion gene signatures and identify transcriptional networks regulating CD2 in various T cell states.

• High-resolution imaging: Analysis of the CD2 corolla formation in exhausted versus functional T cells can reveal structural alterations in the immunological synapse that correlate with functional defects .

• Functional rescue experiments: Determining whether forced expression of CD2 can restore function in exhausted T cells would provide insights into whether CD2 downregulation is a cause or consequence of T cell exhaustion.

Methodology note: Combine these approaches with functional assays measuring T cell responses to varying antigen concentrations to assess whether CD2 downregulation contributes to the higher activation threshold characteristic of exhausted T cells .

What are the contradictions in our understanding of CD2's evolutionary conservation versus functional redundancy?

The apparent contradiction between CD2's strong evolutionary conservation and its seemingly redundant function raises interesting questions:

• Conservation evidence: CD2 is highly conserved throughout mammalian evolution, suggesting important biological functions under selective pressure. The cytoplasmic domain of CD2 shows particularly high conservation across species .

• Functional redundancy: Despite this conservation, CD2-deficient mice have relatively mild phenotypes, suggesting some functional redundancy with other costimulatory pathways .

• Reconciling perspectives: Researchers have proposed that CD2's quantitative effect on T cell antigen recognition provides a survival advantage by enabling responses to lower concentrations of peptide-MHC, allowing earlier immune responses after infection or facilitating elimination of residual infectious agents .

• Repertoire implications: Another hypothesis suggests that CD2-ligand interactions might alter the T cell repertoire selected in the thymus by enabling responses to lower affinity peptide-MHC complexes, effectively increasing the size of the T cell repertoire .

Methodology note: Testing these hypotheses requires sensitive techniques for measuring subtle changes in T cell activation thresholds and sophisticated approaches for assessing small changes in the effective size of the T cell repertoire .

How do we reconcile seemingly contradictory data on CD2 function in different experimental systems?

Researchers face challenges reconciling conflicting data on CD2 function:

• Species-specific differences: As noted earlier, murine and human CD2 have different binding partners and expression patterns, complicating cross-species comparisons. This has led some researchers to caution that "the degree to which data about the role of CD2 in murine immunity can be extrapolated to a human context is uncertain and must be practiced cautiously" .

• Context-dependent effects: CD2's contribution to T cell activation varies with TCR signal strength—it is more important when T cells recognize antigens with lower affinity or at lower concentrations .

• Technical differences: Variations in assay sensitivity, CD2 expression levels, and experimental timelines may contribute to apparently conflicting results across studies.

• Dual functionality hypothesis: The apparent contradiction that elongated CD2-CD48 interactions inhibit T cell activation more than absence of CD2-CD48 has been reconciled with a "dual function" model: CD2 first positions membranes optimally for TCR triggering, then acts as a molecular filter maintaining immunological synapse structure .

Methodology note: When designing experiments to resolve these contradictions, carefully control for CD2 expression levels, TCR signal strength, and temporal aspects of T cell activation, using quantitative readouts whenever possible .